This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
MOUSE ANTI Bcl-6
catalog :
VMA00325
quantity :
100 µl
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
OTI20A3
reactivity :
human
application :
western blot
product information
Entity Category :
Antibodies
Product Code :
VMA00325
Description :
MOUSE ANTI Bcl-6
Specificity :
Bcl-6
Target Species :
Human
Host :
Mouse
Format :
Purified
Isotypes :
IgG1
Applications :
WB
Application Types :
Western Blotting
Clone :
OTI20A3
Quantity :
100 µl
Quantity Value :
100 µl
Quantity Type :
ul
GO Accessions :
GO:0000060, GO:0000122, GO:0005515, GO:0002634, GO:0002903, GO:0003700, GO:0005634, GO:0006974, GO:0008270, GO:0016564, GO:0030308, GO:0043065, GO:0043565, GO:0045749
GO Terms :
activation of apoptosis, alpha-2 macroglobulin receptor-associated protein activity, cell nucleus, cellular DNA damage response, cellular response to DNA damage stimulus, DNA damage response, down regulation of B cell apoptosis, down regulation of cell growth, down regulation of S phase of mitotic cell cycle, down regulation of transcription from RNA polymerase II promoter, downregulation of B cell apoptosis, down-regulation of B cell apoptosis, downregulation of cell growth, down-regulation of cell growth, downregulation of S phase of mitotic cell cycle, down-regulation of S phase of mitotic cell cycle, downregulation of transcription from RNA polymerase II promoter, down-regulation of transcription from RNA polymerase II promoter, GO:0000130, GO:0034984, GO:0045308, inhibition of B cell apoptosis, inhibition of cell growth, inhibition of S phase of mitotic cell cycle, inhibition of transcription from RNA polymerase II promoter, negative regulation of S-phase of mitotic cell cycle, negative regulation of transcription from Pol II promoter, negative transcriptional regulator activity, protein amino acid binding, protein degradation tagging activity, protein folding chaperone, protein import into cell nucleus, translocation, protein tagging activity, protein translocation during protein import into nucleus, protein translocation during protein transport from cytoplasm to nucleus, protein translocation during protein-nucleus import, protein transport from cytoplasm to nucleus, translocation, protein-nucleus import, translocation, response to genotoxic stress, sequence specific DNA binding, stimulation of apoptosis, transcriptional repressor activity, up regulation of apoptosis, upregulation of apoptosis, up-regulation of apoptosis, zinc binding
Uniprot Accessions :
P41182
Gene :
BCL6
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=604
EntityFormats :
Purified
UNSPSC :
41116161
Product Form :
Purified IgG - liquid
PrimarySecondary :
Primary
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.